TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities December 8, 1989